[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346247-105":59,"doc-detail-346247-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","epsteinbarr-virusassociated-tnkcell-neoplasms-review","Epstein–Barr Virus‐Associated T/NK‐Cell Neoplasms - Review","","Epstein–Barr virus (EBV)–associated T- and natural killer (NK)-cell neoplasms form a heterogeneous spectrum, from persistent lymphoproliferative disorders such as severe mosquito bite allergy and systemic chronic active EBV disease to highly aggressive malignancies including extranodal NK/T-cell lymphoma and aggressive NK-cell leukemia. Genomic and epigenetic studies show shared host genetic alterations—especially in JAK–STAT signaling, epigenetic regulators, TP53, and DDX3X—suggesting a pathogenic continuum. Defective EBV reshapes viral gene programs and drives oncogenesis. L-asparaginase-based chemoradiotherapy improves early-stage ENKTL outcomes, while advanced-stage and other EBV-associated T/NK neoplasms lack effective therapies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epsteinbarr-virusassociated-tnkcell-neoplasms-review/346247/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epsteinbarr-virusassociated-tnkcell-neoplasms-review/346247.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What conditions are included within EBV-associated T/NK-cell neoplasms?","Question",{"text":113,"@type":114},"The spectrum includes lymphomas and persistent lymphoproliferative disorders such as systemic chronic active EBV disease, severe mosquito bite allergy, and hydroa vacciniforme lymphoproliferative disorder, as well as aggressive malignancies like extranodal NK/T-cell lymphoma and aggressive NK-cell leukemia.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What shared molecular features support a continuum among these disorders?",{"text":118,"@type":114},"Genomic and epigenetic studies identify shared host genetic alterations, notably affecting JAK–STAT signaling, epigenetic regulators, TP53, and DDX3X, alongside EBV-driven changes in viral gene expression.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is treatment more limited for advanced-stage disease?",{"text":122,"@type":114},"L-asparaginase-based chemoradiotherapy has improved outcomes in early-stage ENKTL, but effective treatments for advanced-stage disease and for other EBV-associated T/NK-cell neoplasms remain limited.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346247,1790932785,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Journal of Medical Virology   \nREVIEW   \nEpstein–Barr Virus‐Associated T/NK‐Cell Neoplasms  \nYoshitaka Sato1  | Yusuke Okuno2 | Takayuki Murata3 | Hiroshi Kimura1  \n1Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan | 2Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan | 3Department of Virology, Fujita Health University School of Medicine, Toyoake, Japan  \nCorrespondence: Yoshitaka Sato ([yssato@med.nagoya-u.ac.jp](yssato@med.nagoya-u.ac.jp))  \nReceived: 23 November 2025 | Revised: 23 December 2025 | Accepted: 4 January 2026  \nFunding: Japan Agency for Medical Research and Development (AMED), Grant/Award Numbers: JP25jm0210115, JP256f0137010; Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant/Award Numbers: JP23K06559, JP23H02723, JP24K22050  \nKeywords: ANKL | CAEBV | EBV | ENKTL | HV‐LPD | T/NK neoplasms  \nABSTRACT  \nEpstein–Barr virus (EBV)‐associated T‐ and natural killer (NK)‐cell neoplasms encompass a heterogeneous spectrum, ranging from persistent lymphoproliferative disorders (e.g., severe mosquito bite allergy, systemic chronic active EBV disease) to highly aggressive malignancies (e.g., extranodal NK/T‐cell lymphoma [ENKTL], aggressive NK‐cell leukemia) . Genomic and epigenetic studies have revealed shared host genetic alterations—most notably in JAK–STAT signaling, epigenetic regulators, TP53, and DDX3X—supporting a pathogenic and clinicobiological continuum across these disorders. Defective EBV further reshapes viral gene expression programs and contributes to oncogenesis. L‐asparaginase‐based chemoradiotherapy has improved outcomes in early‐stage ENKTL; however, effective treatments for advanced‐stage disease and other EBV‐associated T/NK‐cell neoplasms remain limited. Emerging molecular subclassifications and large‐scale prospective cohorts can help clarify disease heterogeneity and accelerate the development of precision therapeutic strategies.  \n1 | Introduction  \nEpstein–Barr virus (EBV), classified as human herpesvirus 4, is a ubiquitous virus that infects more than 90% of the adult population globally. EBV primarily targets B‐ and epithelial cells and is transmitted through saliva [1] . Most infections areasymptomatic; however, EBV occasionally causes infectious mononucleosis in adolescents and young adults and has been related to autoimmune diseases [2] . Moreover, EBV is anoncogenic virus that can immortalize B cells in vitro. It is responsible for approximately 250,000 new cancer cases globally each year, contributing to more than 140,000 cancer‐related deaths annually [3] . EBV infection has been associated with malignancy not only in B‐cell malignancies, such as Burkitt lymphoma, Hodgkin lymphoma, and diffuse large B‐cell lymphoma, but also in epithelial cancers, including gastric carcinoma and nasopharyngeal cancer, as well as in T‐ and natural killer (NK)‐cell neoplasms. T‐ or NK‐cell neoplasms comprise  \nlymphomas and lymphoproliferative disorders (LPDs), with LPDs characterized by the abnormal proliferation and transformation of EBV‐infected T or NK cells [4] . This review aims to summarize the current knowledge of EBV‐associated T/NK‐cell neoplasms, emphasizing their clinical, genetic, and biological characteristics, and to identify key questions that remain unaddressed in this field.  \n2 | EBV‐Associated T/NK‐Cell Neoplasms  \nThe fifth edition of the World Health Organization classification of haematolymphoid tumors (WHO‐HAEM5) [5] defines EBV‐ associated T/NK‐cell neoplasms as a broad disease spectrum encompassing both lymphomas and LPDs, based on the cell of origin or state of differentiation, disease localization, clinical presentation, and cell morphology. Transitions from LPDs toovert lymphomas have been observed; thus, this concept reflects  \nThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any m","cbCaiswueLty5TDU","https://ap.wps.com/l/cbCaiswueLty5TDU","pdf",580397,"English","# Introduction\n# EBV‐Associated T/NK‐Cell Neoplasms\n## Extranodal NK/T‐Cell Lymphoma","[{\"question\":\"What conditions are included within EBV-associated T/NK-cell neoplasms?\",\"answer\":\"The spectrum includes lymphomas and persistent lymphoproliferative disorders such as systemic chronic active EBV disease, severe mosquito bite allergy, and hydroa vacciniforme lymphoproliferative disorder, as well as aggressive malignancies like extranodal NK/T-cell lymphoma and aggressive NK-cell leukemia.\"},{\"question\":\"What shared molecular features support a continuum among these disorders?\",\"answer\":\"Genomic and epigenetic studies identify shared host genetic alterations, notably affecting JAK–STAT signaling, epigenetic regulators, TP53, and DDX3X, alongside EBV-driven changes in viral gene expression.\"},{\"question\":\"Why is treatment more limited for advanced-stage disease?\",\"answer\":\"L-asparaginase-based chemoradiotherapy has improved outcomes in early-stage ENKTL, but effective treatments for advanced-stage disease and for other EBV-associated T/NK-cell neoplasms remain limited.\"}]","Epstein–Barr Virus‐Associated T/NK‐Cell Neoplasms - Review | PDF",1790060624,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d897f68434c9bf5b5f27b4cae67f86f.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1cfd2c25006b71fc3fbd6a2051f78f6f.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b71704148276b540405634b56772a194.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4dce3257a9e9cbef58fe1f8b9ce37445.webp",980,1287]